Long-Term Effects of Angiotensin II Receptor Antagonist Losartan on Uric Acid Metabolism in Hyperuricemic Patients

Gout and Nucleic Acid Metabolism
doi 10.6032/gnam1999.26.1_25
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Gout and Nucleic Acid Metabolism

Related search

Effect of the Angiotensin II Receptor Antagonist Losartan on Uric Acid and Oxypurine Metabolism in Healthy Subjects.

Internal Medicine
Internal MedicineMedicine
2002English

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

Case Reports in Pediatrics
2018English

Patient With Drug-Induced Hepatic Injury Caused by Long-Term Administration of an Angiotesin II Receptor Antagonist, Losartan

Acta Hepatologica Japonica
Hepatology
2013English

Effect of a Reduction in Uric Acid on Renal Outcomes During Losartan Treatment: A Post Hoc Analysis of the Reduction of Endpoints in Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial

Hypertension
Internal Medicine
2011English

Clinical Usefulness of Losartan, an Angiotensin II Receptor Antagonist With a Uricosuric Effect, and the Influence of Aspirin on the Effect in Hypertensive Patients With Hyperuricemia

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2003English

Uric Acid and Long-Term Outcomes in CKD

American Journal of Kidney Diseases
Nephrology
2009English

Effects of Angiotensin II Receptor Antagonist on Endothelial Vasomotor Function and Urinary Albumin Excretion in Type 2 Diabetic Patients With Microalbuminuria

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2002English

Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist on Cardiac Autonomic Functions of Rats During Acute and Chronic Inhibition of Nitric Oxide Synthesis

Physiological Research
MedicinePhysiology
2012English

The Losartan Renal Protection Study--Rationale, Study Design and Baseline Characteristics of RENAAL (Reduction of Endpoints in NIDDM With the Angiotensin II Antagonist Losartan).

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy